Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02341430 · ClinicalTrials.gov registry record · Phase 4
A Longitudinal Prospective Outcomes Study of Laparoscopic Abdominal Wall Hernia Repair Using Symbotex™ Composite Mesh
A Phase 4 study of Grade I Ventral Hernia and Grade II Ventral Hernia, sponsored by Anne Arundel Health System Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT02341430 is a Phase 4 study of Grade I Ventral Hernia and Grade II Ventral Hernia that has completed, run by Anne Arundel Health System Research Institute. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02341430, a Phase 4 study of Grade I Ventral Hernia and Grade II Ventral Hernia, has completed, sponsored by Anne Arundel Health System Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to test the efficacy of Symbotex™ as an effective synthetic mesh option in the repair of grade I and II ventral hernias.
Conditions Studied
Interventions
- DEVICE Symbotex™ Composite Mesh
Study Locations (1)
Maryland
- Anne Arundel Medical Center - Annapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-01 |
| Est. Completion | 2018-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02341430
The ClinicalTrials.gov registry entry for NCT02341430 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Anne Arundel Health System Research Institute, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Grade I Ventral Hernia appearing as the primary indexed condition, and to 1 intervention - of which Symbotex™ Composite Mesh is the first listed.
NCT02341430 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT02341430 about?
NCT02341430 is a clinical study titled "A Longitudinal Prospective Outcomes Study of Laparoscopic Abdominal Wall Hernia Repair Using Symbotex™ Composite Mesh". This study is being done to test the efficacy of Symbotex™ as an effective synthetic mesh option in the repair of grade I and II ventral hernias.
What is the current status of trial NCT02341430?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2016-01. Estimated completion is 2018-12-31.
What conditions does trial NCT02341430 study?
This clinical trial studies the following conditions: Grade I Ventral Hernia, Grade II Ventral Hernia.
What interventions are being tested in trial NCT02341430?
The interventions under investigation include: Symbotex™ Composite Mesh (DEVICE).
Who is sponsoring clinical trial NCT02341430?
This trial is sponsored by Anne Arundel Health System Research Institute, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02341430 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.